Humacyte, Inc. (HUMA)

Last Closing Price: 1.23 (2025-12-05)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Humacyte, Inc. (HUMA) had Net Income of $-17.51M for the most recently reported fiscal quarter, ending 2025-09-30.

Figures for fiscal quarter ending 2025-09-30
Income Statement Financials
$0.75M
Net Income
$-17.51M
$0.26M
$0.49M
$25.14M
$-24.39M
$6.88M
$-17.51M
$-17.51M
$-17.51M
$-17.51M
$-17.51M
$-17.51M
$-24.39M
$-22.52M
158.31M
158.31M
$-0.11
$-0.11
Balance Sheet Financials
$41.35M
$19.86M
$50.16M
$91.51M
$25.58M
$27.16M
$70.68M
$96.26M
$-4.75M
$-4.75M
$-4.75M
158.84M
Cash Flow Statement Financials
$-78.92M
$-0.84M
$4.31M
$95.29M
$19.84M
$-75.45M
$7.28M
--
--
Fundamental Metrics & Ratios
1.62
--
--
1.21
-6.28
65.47%
-3239.04%
-3239.04%
--
-2325.36%
-2325.36%
$-79.76M
--
--
--
0.01
0.01
0.70
128.84
368.55%
368.55%
-19.13%
-78.16%
$-0.03
$-0.50
$-0.50